1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Triple Therapy: new trials by email Literature Review of Triple Therapy trials Research Report on Triple Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study Budesonide/Glycopyrronium/Formoterol (BGF), Fluticasone Furoate/Umeclidinium/Vilanterol (FUV) - COPD, Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Thammasat University | 22 | 2025-04-01 | 2026-02-02 |
| Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy | Phase 4 | Unknown | Yanqing Li | 120 | 2017-05-30 | 2017-05-03 |
Pulmonary Disease, Chronic Obstructive (1)
Chronic Disease (1) · Disease Attributes (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Amoxicillin (1) · Budesonide (1) · Clarithromycin (1) · Furazolidone (1) · Levofloxacin (1) · Tetracycline (1) · Tinidazole (1) · fluticasone furoate (1) · ilaprazole (1)
Thammasat University (1) · Yanqing Li (1)
Thailand (1)
Li Yanqing, MD, PhD (1) · Narongkorn Saiphoklang, MD (1)
PMID 25180727, PMID 26557240, PMID 28375647, PMID 29370819, PMID 30232048, PMID 31688242, PMID 32103926, PMID 33116458, PMID 34035312, PMID 34171789, PMID 34428980, PMID 34620167, PMID 37742015, PMID 38055196, PMID 39046133, PMID 39219564, PMID 39458663